NCT00919880.

Study name	Comparison of neo‐adjuvant weekly paclitaxel with or without carboplatin in early breast cancer
Methods	Accrual: completed, no results posted in ClinicalTrials.gov Accrual target: 148 Single‐centre, phase 2 RCT Trial is being conducted in China Blinding: open‐label study
Participants	People with medium‐ and high‐risk primary breast cancer Adjuvant or neoadjuvant: neoadjuvant
Interventions	Arm 1: intervention: carboplatin AUC2 mg/mL every 3 weeks for 4 cycles and paclitaxel 80 mg/m2 every 3 weeks for 4 cycles Arm 2: comparator: paclitaxel 80 mg/m2 every 3 weeks for 4 cycles
Outcomes	Primary Significant effect rate (proportion of G4 and G5 as per Miller & Payne method) Secondary: none listed
Starting date	Planned start date: July 2009 Actual completion date: December 2010
Contact information	Contact: Tanfeng Wang (no contact details listed)
Notes	Trial registration link: clinicaltrials.gov/ct2/show/NCT00919880 Trial sponsor: Tao Ouyang Funding considerations: not provided in trial record